Latest News

Ethical use of Off-label disease-modifying therapies used in MS

August 3, 2021 | Education, Treatments, Uncategorised

The MS International Federation’s Atlas of MS showed that off-label disease-modifying therapies are used in at least 89 countries. This highlights the need for  transparent evidence-based guidelines to support clinical decision-making, pharmaceutical policies and reimbursement decisions.  Because there has been […]